Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $13
LifeStance Health
LifeStance Health LFST | 0.00 |
Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:
LFST) with a Buy and raises the price target from $11 to $13.
